ArticleJPGN reports2026

Ruxolitinib and vedolizumab salvage therapy in the setting of cytomegalovirus colitis for a patient with newly diagnosed very early onset inflammatory bowel disease.

Alison Laxer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.